Patsy Patricia McDonald

Senior Director, Biology @Lexicon Pharmaceuticals, Inc.

Tampa, FL, US
EMAILS
p••••••••@lexpharma.com
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Mar 2023 — Present

Senior Director, Biology @Lexicon Pharmaceuticals, Inc.

View department →

EDUCATION

1996 — 2000

Duke University

GPCR function and regulation

1989 — 1993

University of Dundee

PhD, Molecular Genetics

1993 — 1995

University of Glasgow

Molecular biology/ Gene Therapy

SKILLS

High Content ImagingAssay DevelopmentMolecularIn VivoTissue CultureHigh Throughput ScreeningDnaIn Vitro PharmacologyDrug DesignMetabolic DiseaseElisaCell BiologyPharmacokineticsMolecular BiologyGpcrsTranslational ScienceBiotechnologyProtein PurificationDrug DiscoveryBiochemistryPharmacologyCell CultureBioinformaticsLifesciencesProtein ExpressionMetabolismNeuroscienceWestern BlottingMolecularLife SciencesIn VitroTransfectionSignal TransductionCell SignalingHigh Content Screening

ABOUT PATSY PATRICIA MCDONALD

G protein-coupled receptors (GPCRs) are the largest and most versatile family of cell-surface receptors. The ubiquitous cell-surface distribution and involvement of these proteins in almost all biological processes explain why the largest percentage of currently marketed therapeutic drugs, target these receptors. My laboratory is focused on investigating the molecular mechanisms underlying the regulation, trafficking and activation of GPCRs involved in metabolic disorders and cancer. Knowledge gained from these studies may aid in the design of therapeutically useful GPCR modulators. In addition my laboratory develops biochemical and cell-based functional assays to monitor GPCR activity that involve high-throughput and high-content technologies. Using a multidisciplinary approach that involves collaborations with disciplines such as lead identification, chemistry, drug metabolism and pharmacokinetics, and in vivo pharmacology, we aim to integrate basic research and drug discovery practices in order to identify and develop biologics and small-molecule modulators of GPCRs for the treatment of metabolic disorders, cancer and cancer associated cachexia.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.